These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14698449)

  • 1. A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Harris JM; Pritchard A; Lambert JC; Chartier-Harlin MC; Pickering-Brown SM; Lendon CL; Mann DM
    Neurosci Lett; 2004 Jan; 354(2):103-6. PubMed ID: 14698449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease.
    Lendon CL; Thaker U; Harris JM; McDonagh AM; Lambert JC; Chartier-Harlin MC; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neurosci Lett; 2002 Aug; 328(3):314-8. PubMed ID: 12147333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction.
    Um JY; Moon KS; Lee KM; Cho KH; Heo Y; Moon BS; Kim HM
    J Mol Neurosci; 2003; 21(1):23-8. PubMed ID: 14500990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease.
    Isbir T; Agaçhan B; Yilmaz H; Aydin M; Kara I; Eker D; Eker E
    Am J Alzheimers Dis Other Demen; 2001; 16(4):205-10. PubMed ID: 11501342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.
    Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM
    J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk.
    Panza F; Solfrizzi V; D'Introno A; Colacicco AM; Capurso C; Capurso A; Kehoe PG
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1159-61. PubMed ID: 12876265
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Angiotensin-converting enzyme insertion(I)/deletion (D) genotype in Alzheimer's disease patients of north Indian population.
    Nirmal S; Tripathi M; Shastri SS; Sagar R; S V
    Int J Neurosci; 2011 Oct; 121(10):557-61. PubMed ID: 21770707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme insertion/deletion polymorphism is associated with cerebral white matter changes in Alzheimer's disease.
    Chou PS; Wu SJ; Kao YH; Chou MC; Tai SY; Yang YH
    Geriatr Gerontol Int; 2017 Jun; 17(6):945-950. PubMed ID: 27273771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis.
    Szolnoki Z; Somogyvári F; Kondacs A; Szabó M; Fodor L; Bene J; Melegh B
    Acta Neurol Scand; 2004 Mar; 109(3):222-7. PubMed ID: 14763962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala.
    Sleegers K; den Heijer T; van Dijk EJ; Hofman A; Bertoli-Avella AM; Koudstaal PJ; Breteler MM; van Duijn CM
    Neurobiol Aging; 2005; 26(8):1153-9. PubMed ID: 15917098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
    Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
    Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease.
    Monastero R; Caldarella R; Mannino M; Cefalù AB; Lopez G; Noto D; Camarda C; Camarda LK; Notarbartolo A; Averna MR; Camarda R
    Neurosci Lett; 2002 Dec; 335(2):147-9. PubMed ID: 12459519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Apo E and ACE genes to cognitive performance in chronic alcoholic patients.
    Bartrés-Faz D; Clemente IC; Monràs M; Muñoz M; López-Alomar A; Valveny N; Moral P; Gual A; Sánchez-Turet M; Guardia J; Junqué C
    Addict Biol; 2002 Apr; 7(2):227-33. PubMed ID: 12006218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.
    Lehmann DJ; Cortina-Borja M; Warden DR; Smith AD; Sleegers K; Prince JA; van Duijn CM; Kehoe PG
    Am J Epidemiol; 2005 Aug; 162(4):305-17. PubMed ID: 16033878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease.
    Reid RT; Sabbagh MN; Thal LJ
    J Neural Transm (Vienna); 2001; 108(8-9):1043-50. PubMed ID: 11716140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy.
    Masullo C; Daniele A; Fazio VM; Seripa D; Gravina C; Filippini V; Grossi D; Fragassi N; Nichelli P; Leone M; Gainotti G
    Neurosci Lett; 2001 May; 303(2):87-90. PubMed ID: 11311499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.